Joint association of the inflammatory marker and cardiovascular-kidney-metabolic syndrome stages with all-cause and cardiovascular disease mortality: a national prospective study

Abstract Background Cardiovascular-kidney-metabolic (CKM) syndrome and systemic inflammation significantly contribute to mortality. However, the joint associations of CKM stages and systemic inflammation with all-cause and cardiovascular disease (CVD) mortality remain unclear. This study aimed to ev...

Full description

Saved in:
Bibliographic Details
Main Authors: Yifei Cao, Wenfeng Wang, Shidong Xie, Yanfang Xu, Zishan Lin
Format: Article
Language:English
Published: BMC 2025-01-01
Series:BMC Public Health
Subjects:
Online Access:https://doi.org/10.1186/s12889-024-21131-2
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841559064264310784
author Yifei Cao
Wenfeng Wang
Shidong Xie
Yanfang Xu
Zishan Lin
author_facet Yifei Cao
Wenfeng Wang
Shidong Xie
Yanfang Xu
Zishan Lin
author_sort Yifei Cao
collection DOAJ
description Abstract Background Cardiovascular-kidney-metabolic (CKM) syndrome and systemic inflammation significantly contribute to mortality. However, the joint associations of CKM stages and systemic inflammation with all-cause and cardiovascular disease (CVD) mortality remain unclear. This study aimed to evaluate the independent and joint associations of CKM stages and systemic inflammation with all-cause and CVD mortality in a representative cohort of United States adults. Methods We analyzed data from 29,459 adults aged ≥ 20 years from the National Health and Nutrition Examination Survey (1999–2018). CKM stages were classified based on metabolic risk factors, CVD, and chronic kidney disease. Systemic inflammation was assessed using multiple indicators, and time-dependent ROC analysis identified the systemic inflammatory response index (SIRI) as the most effective inflammatory marker. The associations of CKM stages and SIRI with mortality were evaluated. Results Over a median follow-up of 109 months, 5,583 all-cause deaths and 1,843 CVD-specific deaths occurred. Both advanced CKM stages and elevated SIRI were associated with higher risks of all-cause and CVD mortality. Individuals with advanced CKM stages (Stages 3–4) and elevated SIRI (> 0.81) had the highest risks of all-cause (HR: 1.84, 95% CI: 1.65–2.05) and CVD mortality (HR: 2.50, 95% CI: 2.00–3.12). These associations were particularly pronounced in adults aged < 60 years (P for interaction < 0.001). Conclusions Advanced CKM stages and elevated SIRI are associated with increased risks of all-cause and CVD mortality, particularly in younger adults. These findings highlight the significance of targeted interventions to address systemic inflammation and CKM progression, potentially improving long-term outcomes in high-risk populations.
format Article
id doaj-art-575658d2aad040cb91f2d788d8958bf0
institution Kabale University
issn 1471-2458
language English
publishDate 2025-01-01
publisher BMC
record_format Article
series BMC Public Health
spelling doaj-art-575658d2aad040cb91f2d788d8958bf02025-01-05T12:48:48ZengBMCBMC Public Health1471-24582025-01-0125111110.1186/s12889-024-21131-2Joint association of the inflammatory marker and cardiovascular-kidney-metabolic syndrome stages with all-cause and cardiovascular disease mortality: a national prospective studyYifei Cao0Wenfeng Wang1Shidong Xie2Yanfang Xu3Zishan Lin4The First Clinical Medical College of Fujian Medical University, the First Affiliated Hospital of Fujian Medical UniversityThe First Clinical Medical College of Fujian Medical University, the First Affiliated Hospital of Fujian Medical UniversityThe First Clinical Medical College of Fujian Medical University, the First Affiliated Hospital of Fujian Medical UniversityThe First Clinical Medical College of Fujian Medical University, the First Affiliated Hospital of Fujian Medical UniversityThe First Clinical Medical College of Fujian Medical University, the First Affiliated Hospital of Fujian Medical UniversityAbstract Background Cardiovascular-kidney-metabolic (CKM) syndrome and systemic inflammation significantly contribute to mortality. However, the joint associations of CKM stages and systemic inflammation with all-cause and cardiovascular disease (CVD) mortality remain unclear. This study aimed to evaluate the independent and joint associations of CKM stages and systemic inflammation with all-cause and CVD mortality in a representative cohort of United States adults. Methods We analyzed data from 29,459 adults aged ≥ 20 years from the National Health and Nutrition Examination Survey (1999–2018). CKM stages were classified based on metabolic risk factors, CVD, and chronic kidney disease. Systemic inflammation was assessed using multiple indicators, and time-dependent ROC analysis identified the systemic inflammatory response index (SIRI) as the most effective inflammatory marker. The associations of CKM stages and SIRI with mortality were evaluated. Results Over a median follow-up of 109 months, 5,583 all-cause deaths and 1,843 CVD-specific deaths occurred. Both advanced CKM stages and elevated SIRI were associated with higher risks of all-cause and CVD mortality. Individuals with advanced CKM stages (Stages 3–4) and elevated SIRI (> 0.81) had the highest risks of all-cause (HR: 1.84, 95% CI: 1.65–2.05) and CVD mortality (HR: 2.50, 95% CI: 2.00–3.12). These associations were particularly pronounced in adults aged < 60 years (P for interaction < 0.001). Conclusions Advanced CKM stages and elevated SIRI are associated with increased risks of all-cause and CVD mortality, particularly in younger adults. These findings highlight the significance of targeted interventions to address systemic inflammation and CKM progression, potentially improving long-term outcomes in high-risk populations.https://doi.org/10.1186/s12889-024-21131-2Cardiovascular-kidney-metabolic syndromeSystemic inflammatory response indexCardiovascular diseaseObesityChronic kidney disease
spellingShingle Yifei Cao
Wenfeng Wang
Shidong Xie
Yanfang Xu
Zishan Lin
Joint association of the inflammatory marker and cardiovascular-kidney-metabolic syndrome stages with all-cause and cardiovascular disease mortality: a national prospective study
BMC Public Health
Cardiovascular-kidney-metabolic syndrome
Systemic inflammatory response index
Cardiovascular disease
Obesity
Chronic kidney disease
title Joint association of the inflammatory marker and cardiovascular-kidney-metabolic syndrome stages with all-cause and cardiovascular disease mortality: a national prospective study
title_full Joint association of the inflammatory marker and cardiovascular-kidney-metabolic syndrome stages with all-cause and cardiovascular disease mortality: a national prospective study
title_fullStr Joint association of the inflammatory marker and cardiovascular-kidney-metabolic syndrome stages with all-cause and cardiovascular disease mortality: a national prospective study
title_full_unstemmed Joint association of the inflammatory marker and cardiovascular-kidney-metabolic syndrome stages with all-cause and cardiovascular disease mortality: a national prospective study
title_short Joint association of the inflammatory marker and cardiovascular-kidney-metabolic syndrome stages with all-cause and cardiovascular disease mortality: a national prospective study
title_sort joint association of the inflammatory marker and cardiovascular kidney metabolic syndrome stages with all cause and cardiovascular disease mortality a national prospective study
topic Cardiovascular-kidney-metabolic syndrome
Systemic inflammatory response index
Cardiovascular disease
Obesity
Chronic kidney disease
url https://doi.org/10.1186/s12889-024-21131-2
work_keys_str_mv AT yifeicao jointassociationoftheinflammatorymarkerandcardiovascularkidneymetabolicsyndromestageswithallcauseandcardiovasculardiseasemortalityanationalprospectivestudy
AT wenfengwang jointassociationoftheinflammatorymarkerandcardiovascularkidneymetabolicsyndromestageswithallcauseandcardiovasculardiseasemortalityanationalprospectivestudy
AT shidongxie jointassociationoftheinflammatorymarkerandcardiovascularkidneymetabolicsyndromestageswithallcauseandcardiovasculardiseasemortalityanationalprospectivestudy
AT yanfangxu jointassociationoftheinflammatorymarkerandcardiovascularkidneymetabolicsyndromestageswithallcauseandcardiovasculardiseasemortalityanationalprospectivestudy
AT zishanlin jointassociationoftheinflammatorymarkerandcardiovascularkidneymetabolicsyndromestageswithallcauseandcardiovasculardiseasemortalityanationalprospectivestudy